Skip to main content
MicroPort CardioFlow Medtech Corporation logo

MicroPort CardioFlow Medtech Corporation — Investor Relations & Filings

Ticker · 2160 ISIN · KYG6082P1138 LEI · 254900V03B971A7FK886 HKEX Manufacturing
Open in API
Filings indexed 298 across all filing types
Latest filing 2026-05-11 Proxy Solicitation & In…
Country KY Cayman Islands
Listing HKEX 2160

About MicroPort CardioFlow Medtech Corporation

http://www.cardioflowmedtech.com

MicroPort CardioFlow Medtech Corporation develops and commercializes innovative transcatheter and surgical solutions for structural heart intervention and cardiac rhythm management. The core business focuses on treating valvular heart diseases (aortic and mitral) and left atrial appendage occlusion. Key commercialized products include the VitaFlow Liberty® TAVI system, recognized globally as the only electric recoverable transcatheter aortic valve implantation device, and the AnchorMan® Left Atrial Appendage Occluder System, which holds dual NMPA and CE MDR approvals. Following the strategic merger with MicroPort CRM in late 2025, the company expanded its scope to build a global heart failure treatment platform, driving international commercialization of its portfolio across major global markets.

Recent filings

Filing Released Lang Actions
FORM OF PROXY FOR USE AT THE ANNUAL GENERAL MEETING TO BE HELD ON THURSDAY, JUNE 4, 2026
Proxy Solicitation & Information Statement Classification · 92% confidence The document is a "Form of Proxy" for the Annual General Meeting, providing shareholders with instructions and an appointment form to vote on resolutions. This is a proxy solicitation document, not the actual Annual Report or meeting presentation. It fits the definition of a Proxy Solicitation & Information Statement (PSI).
2026-05-11 English
NOTICE OF ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 92% confidence The document is a formal notice of the company’s Annual General Meeting, listing resolutions to be voted on, instructions on record dates, proxy appointment procedures, and proxy lodging details. It is sent to shareholders to provide information and request votes for the meeting, matching the definition of a Proxy Solicitation & Information Statement.
2026-05-11 English
(1) PROPOSED GRANTING OF GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE NEW SHARES; (2) PROPOSED RE-ELECTION OF THE RETIRING DIRECTORS; (3) PROPOSED RE-APPOINTMENT OF AUDITOR; AND (4) NOTICE OF AN
Proxy Solicitation & Information Statement Classification · 90% confidence The document is a shareholder circular for MicroPort CardioFlow Medtech Corporation in advance of its Annual General Meeting, containing the notice of meeting, explanatory statements on resolutions (granting share repurchase/issuance mandates, re-election of directors, auditor appointment), and an accompanying form of proxy. It is not the AGM presentation itself nor full financial report but rather proxy solicitation and informational materials for voting at a shareholder meeting.
2026-05-11 English
VOLUNTARY ANNOUNCEMENT - CE APPROVAL OF ENOTM SERIES PACEMAKER FOR LBBAP INDICATION
Regulatory Filings Classification · 64% confidence The document is a corporate "voluntary announcement" filed on the Hong Kong Exchange, providing business and product update (CE approval of a pacemaker). It contains no financial results, no shareholder vote results, no board changes, no financing or M&A details, and no attached full report. It is a general exchange announcement that does not fit other specific categories, making it a fallback Regulatory Filing (RNS).
2026-05-10 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2026
Regulatory Filings
2026-05-07 English
2025 Annual Report
Regulatory Filings
2026-04-28 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.